Lymphoma Current Events | Lymphoma News | 6
|
| Page
6 of
7 |
128 Results |
|
|
|
Sort By:
Page Views | Date |
Mayo researchers find race has role in incidence, survival of rare brain tumor
The incidence of a rare and deadly tumor called primary central nervous system lymphoma (PCNSL) is two times higher in black Americans, ages 20 to 49, than in white Americans, according to a Mayo Clinic study published in the June issue of Journal of Neuro-Oncology. view more (2009-07-31)
Protein complex key in avoiding DNA repair mistakes, cancer
As the body creates antibodies to fight invaders, a three-protein DNA repair complex called MRN is crucial for a normal gene-shuffling process to proceed properly, University of Michigan research shows. view more (2009-08-05)
Research identifies successful new treatment for Hodgkin's lymphoma, reduces long-term risks
New research led by Cindy Schwartz, MD, of Hasbro Children's Hospital has identified a new chemotherapy regimen for pediatric Hodgkin lymphoma (HL) patients. view more (2009-07-14)
Improved diagnostic technology for Crohn's disease
The diagnostic value of CT enteroclysis is superior to conventional enteroclysis, previously considered the gold standard, as an imaging method for the evaluation of the small bowel in patients with Crohn's disease, a new study shows. view more (2006-01-31)
Research suggests new cellular targets for HIV drug development
Focusing HIV drug development on immune cells called macrophages instead of traditionally targeted T cells could bring us closer to eradicating the disease, according to new research from University of Florida and five other institutions. view more (2009-05-28)
Studying cancer in pet dogs to find new treatments for human patients
A team of scientists at the National Cancer Institute (NCI) in Bethesda, USA, says that studying pet dogs with cancer could yield valuable information on how to diagnose and treat human cancers. view more (2009-10-13)
UBC research finds molecular
University of British Columbia researchers have discovered a "molecular key" that could help increase the success of blood stem cell transplants, a procedure currently used to treat diseases such as leukemia, Hodgkin's lymphoma and aplastic anemia. view more (2009-04-23)
Tulane pioneers novel ovarian cancer treatment
The Tulane University Section of Hematology and Medical Oncology is investigating a novel treatment for ovarian cancer by using intravenous Ontak to deplete harmful cells that inhibit the body's natural immune response to fight cancer. Ovarian cancer is the fifth leading cancer killer of women in the United States. view more (2005-07-18)
New treatment approach promising for lymphoma patients in the developing world
Preliminary results suggest that patients with aggressive non-Hodgkin's lymphoma in the developing world might benefit from a modified chemotherapy regimen, researchers say. view more (2008-07-07)
Severe Sepsis Causes Almost 10% Of Cancer Deaths
Severe sepsis, is a costly complication in hospitalized cancer patients causing around one in ten cancer deaths each year in the USA, according to an article published today in Critical Care. The excessive response to infection in patients with severe sepsis injures critical organs such as the lungs and kidneys. Dr Mark Williams and his colleagues... view more... (2004-07-01)
Cancer could return unless stored ovarian tissue undergoes adequate testing before re-implantation
Cancer patients who have been successfully treated for their disease face the prospect of its return if stored ovarian (or testicular) tissue is transplanted back into their bodies without adequate checks, according to researchers at two university hospitals in Israel. view more (2008-04-22)
DECREASE IN AIDS-RELATED ILLNESS IN EUROPE (p 291)
During 1996 and 1997, highly active antiretroviral therapy (HAART) was introduced to treat HIV-1-infected patients who had low CD4-cell counts. In this week's issue of THE LANCET, A Mocroft and colleagues report findings from the EuroSIDA study, which looked at the change in incidence of AIDS-defining illnesses (ADIs) since the introduction of... view more... (2000-07-19)
New test proves effective in more cancers
Avantogen Limited (ACU:ASX) today announced that cancer researchers at Perth's Telethon Institute for Child Health Research (TICHR) and Avantogen Limited have achieved an important milestone towards more individually targeted and effective treatments for cancer patients. view more (2005-10-07)
Activating protein enhances average lifespan, limits age-related disease in mice
Metabolism researchers at Washington University School of Medicine in St. Louis have found that although it does not extend maximum lifespan in mice, activating a protein in muscle tissue increases average lifespan and prevents some age-related diseases. view more (2007-12-05)
Kidney transplantation linked with increased risk of various cancers
Following kidney transplantation, some recipients may face a 3-fold increased risk of certain cancer types, according to a study in the December 20 issue of JAMA. view more (2006-12-20)
Childhood cancer survivors at increased risk of sarcoma
Survivors of childhood cancers have a ninefold increased risk of developing a secondary sarcoma—a cancer of connective or supportive tissue such as bone, fat, or muscle—compared with the general population. view more (2007-02-21)
Glue inside the cell: Ubiquitin builds up an immune response
Ubiquitin is a small protein, which can be attached to other cellular proteins, a process known as ubiquitination. Discoveries in the 1980 th on a key function of ubiquitination in the regulation of protein degradation where awarded with the Nobel Prize for chemistry in 2004. view more (2007-10-22)
Stopping autoimmunity before it strikes
Current research describes a new method to track the development of autoimmune diseases before the onset of symptoms. The related report by Zangani et al, "Tracking early autoimmune disease by bioluminescent imaging of NF-κB activation reveals pathology in multiple organ systems," appears in the April 2009 issue of The American... view more... (2009-03-25)
New findings show Enbrel significantly reduced levels of C-reactive protein
Amgen (NASDAQ: AMGN) and Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), today announced findings from a retrospective analysis, which demonstrated that ENBREL reduced C-reactive protein (CRP), a marker of inflammation, in patients with moderate to severe plaque psoriasis following 12 weeks of treatment. view more (2008-02-04)
Cancer mortality rates experience steady decline
The number of cancer deaths has declined steadily in the last three decades. Although younger people have experienced the steepest declines, all age groups have shown some improvement. view more (2009-08-13)
|
|
| Page
6 of
7 |
128 Results |
|
|
|
Sort By:
Page Views | Date |
|
